Arrowstreet Capital, Limited Partnership Taro Pharmaceutical Industries LTD Transaction History
Arrowstreet Capital, Limited Partnership
- $108 Billion
- Q1 2024
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Taro Pharmaceutical Industries LTD stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 58,888 shares of TARO stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
58,888
Previous 39,556
48.87%
Holding current value
$0
Previous $1.65 Million
50.82%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding TARO
# of Institutions
93Shares Held
4.64MCall Options Held
7KPut Options Held
6.3K-
Krensavage Asset Management, LLC New York, NY648KShares$012.16% of portfolio
-
Black Rock Inc. New York, NY616KShares$00.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny571KShares$00.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX520KShares$00.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA284KShares$00.16% of portfolio
About TARO PHARMACEUTICAL INDUSTRIES LTD
- Ticker TARO
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 37,584,600
- Description
- Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...